Align Technology, Inc. (ALGN)
USD 152.83
(-0.91%)
USD 152.83
(-0.91%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.71 Billion USD | 3.23% |
| 2022 | 2.63 Billion USD | -10.27% |
| 2021 | 2.93 Billion USD | 66.48% |
| 2020 | 1.76 Billion USD | 1.11% |
| 2019 | 1.74 Billion USD | 20.45% |
| 2018 | 1.44 Billion USD | 29.63% |
| 2017 | 1.11 Billion USD | 37.0% |
| 2016 | 815.29 Million USD | 27.37% |
| 2015 | 640.11 Million USD | 10.66% |
| 2014 | 578.44 Million USD | 16.13% |
| 2013 | 498.1 Million USD | 19.63% |
| 2012 | 416.38 Million USD | 15.25% |
| 2011 | 361.28 Million USD | 19.07% |
| 2010 | 303.41 Million USD | 29.95% |
| 2009 | 233.49 Million USD | 3.72% |
| 2008 | 225.12 Million USD | 7.56% |
| 2007 | 209.29 Million USD | 47.83% |
| 2006 | 141.57 Million USD | -1.23% |
| 2005 | 143.34 Million USD | 24.32% |
| 2004 | 115.3 Million USD | 62.03% |
| 2003 | 71.16 Million USD | 142.0% |
| 2002 | 29.4 Million USD | 6678.3% |
| 2001 | -447 Thousand USD | 96.69% |
| 2000 | -13.51 Million USD | -905.96% |
| 1999 | -1.34 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 703.26 Million USD | 4.5% |
| 2024 Q3 | 670.81 Million USD | -6.37% |
| 2024 Q2 | 728.13 Million USD | 3.54% |
| 2023 Q4 | 672.97 Million USD | 1.49% |
| 2023 Q1 | 660.65 Million USD | 6.95% |
| 2023 Q2 | 713.6 Million USD | 8.02% |
| 2023 Q3 | 663.07 Million USD | -7.08% |
| 2023 FY | 2.71 Billion USD | 3.23% |
| 2022 Q3 | 619.16 Million USD | -9.95% |
| 2022 FY | 2.63 Billion USD | -10.27% |
| 2022 Q4 | 617.7 Million USD | -0.24% |
| 2022 Q2 | 687.55 Million USD | -3.07% |
| 2022 Q1 | 709.34 Million USD | -4.73% |
| 2021 Q3 | 755.15 Million USD | -0.45% |
| 2021 Q4 | 744.56 Million USD | -1.4% |
| 2021 Q2 | 758.53 Million USD | 12.03% |
| 2021 Q1 | 677.09 Million USD | 10.92% |
| 2021 FY | 2.93 Billion USD | 66.48% |
| 2020 FY | 1.76 Billion USD | 1.11% |
| 2020 Q4 | 610.46 Million USD | 14.3% |
| 2020 Q2 | 224.32 Million USD | -43.12% |
| 2020 Q1 | 394.35 Million USD | -16.44% |
| 2020 Q3 | 534.08 Million USD | 138.08% |
| 2019 Q2 | 432.28 Million USD | 7.51% |
| 2019 Q1 | 402.09 Million USD | 4.96% |
| 2019 Q3 | 437.55 Million USD | 1.22% |
| 2019 Q4 | 471.95 Million USD | 7.86% |
| 2019 FY | 1.74 Billion USD | 20.45% |
| 2018 Q1 | 327.4 Million USD | 2.99% |
| 2018 FY | 1.44 Billion USD | 29.63% |
| 2018 Q2 | 365.58 Million USD | 11.66% |
| 2018 Q3 | 371.78 Million USD | 1.7% |
| 2018 Q4 | 383.09 Million USD | 3.04% |
| 2017 Q1 | 235.62 Million USD | 6.98% |
| 2017 FY | 1.11 Billion USD | 37.0% |
| 2017 Q2 | 270.91 Million USD | 14.98% |
| 2017 Q3 | 292.48 Million USD | 7.96% |
| 2017 Q4 | 317.91 Million USD | 8.69% |
| 2016 Q2 | 205.21 Million USD | 13.61% |
| 2016 FY | 815.29 Million USD | 27.37% |
| 2016 Q4 | 220.24 Million USD | 5.28% |
| 2016 Q3 | 209.2 Million USD | 1.94% |
| 2016 Q1 | 180.62 Million USD | 4.52% |
| 2015 Q4 | 172.81 Million USD | 9.67% |
| 2015 FY | 640.11 Million USD | 10.66% |
| 2015 Q1 | 151.09 Million USD | 0.28% |
| 2015 Q2 | 158.63 Million USD | 4.99% |
| 2015 Q3 | 157.57 Million USD | -0.67% |
| 2014 FY | 578.44 Million USD | 16.13% |
| 2014 Q2 | 145.47 Million USD | 5.99% |
| 2014 Q1 | 137.25 Million USD | 0.57% |
| 2014 Q3 | 145.05 Million USD | -0.29% |
| 2014 Q4 | 150.66 Million USD | 3.87% |
| 2013 Q3 | 125.09 Million USD | 1.13% |
| 2013 Q1 | 112.84 Million USD | 5.98% |
| 2013 FY | 498.1 Million USD | 19.63% |
| 2013 Q4 | 136.47 Million USD | 9.1% |
| 2013 Q2 | 123.69 Million USD | 9.61% |
| 2012 Q3 | 100.35 Million USD | -7.77% |
| 2012 Q4 | 106.47 Million USD | 6.11% |
| 2012 Q1 | 100.76 Million USD | 5.45% |
| 2012 FY | 416.38 Million USD | 15.25% |
| 2012 Q2 | 108.8 Million USD | 7.98% |
| 2011 FY | 361.28 Million USD | 19.07% |
| 2011 Q1 | 82.22 Million USD | 14.59% |
| 2011 Q2 | 91.13 Million USD | 10.84% |
| 2011 Q3 | 92.37 Million USD | 1.35% |
| 2011 Q4 | 95.55 Million USD | 3.44% |
| 2010 Q4 | 71.75 Million USD | -4.24% |
| 2010 FY | 303.41 Million USD | 29.95% |
| 2010 Q2 | 87.01 Million USD | 24.83% |
| 2010 Q1 | 69.71 Million USD | 9.25% |
| 2010 Q3 | 74.93 Million USD | -13.89% |
| 2009 Q2 | 57.97 Million USD | 10.0% |
| 2009 FY | 233.49 Million USD | 3.72% |
| 2009 Q3 | 59 Million USD | 1.76% |
| 2009 Q4 | 63.8 Million USD | 8.14% |
| 2009 Q1 | 52.7 Million USD | -2.2% |
| 2008 Q4 | 53.89 Million USD | -4.46% |
| 2008 FY | 225.12 Million USD | 7.56% |
| 2008 Q3 | 56.4 Million USD | -5.45% |
| 2008 Q2 | 59.65 Million USD | 8.14% |
| 2008 Q1 | 55.16 Million USD | 3.33% |
| 2007 Q1 | 46.23 Million USD | 21.68% |
| 2007 Q2 | 56.35 Million USD | 21.9% |
| 2007 Q3 | 53.31 Million USD | -5.39% |
| 2007 FY | 209.29 Million USD | 47.83% |
| 2007 Q4 | 53.39 Million USD | 0.13% |
| 2006 Q4 | 37.99 Million USD | 17.83% |
| 2006 FY | 141.57 Million USD | -1.23% |
| 2006 Q3 | 32.24 Million USD | -12.21% |
| 2006 Q1 | 34.61 Million USD | 0.46% |
| 2006 Q2 | 36.72 Million USD | 6.12% |
| 2005 FY | 143.34 Million USD | 24.32% |
| 2005 Q1 | 35.67 Million USD | 24.34% |
| 2005 Q2 | 37.32 Million USD | 4.61% |
| 2005 Q4 | 34.45 Million USD | -4.01% |
| 2005 Q3 | 35.89 Million USD | -3.83% |
| 2004 FY | 115.3 Million USD | 62.03% |
| 2004 Q1 | 25.81 Million USD | 9.48% |
| 2004 Q2 | 29.95 Million USD | 16.05% |
| 2004 Q3 | 30.84 Million USD | 2.97% |
| 2004 Q4 | 28.69 Million USD | -6.97% |
| 2003 FY | 71.16 Million USD | 142.0% |
| 2003 Q2 | 15.95 Million USD | 23.45% |
| 2003 Q4 | 23.57 Million USD | 14.49% |
| 2003 Q1 | 12.92 Million USD | 21.99% |
| 2003 Q3 | 20.59 Million USD | 29.05% |
| 2002 Q1 | 4.63 Million USD | 118.89% |
| 2002 FY | 29.4 Million USD | 6678.3% |
| 2002 Q4 | 10.59 Million USD | 37.72% |
| 2002 Q3 | 7.69 Million USD | 18.7% |
| 2002 Q2 | 6.48 Million USD | 39.8% |
| 2001 Q2 | -347 Thousand USD | 85.33% |
| 2001 Q1 | -2.36 Million USD | 0.0% |
| 2001 FY | -447 Thousand USD | 96.69% |
| 2001 Q4 | 2.11 Million USD | 28.6% |
| 2001 Q3 | 1.64 Million USD | 574.64% |
| 2000 FY | -13.51 Million USD | -905.96% |
| 2000 Q1 | -1.39 Million USD | 0.0% |
| 1999 FY | -1.34 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -106516.392% |
| BrainsWay Ltd. | 23.09 Million USD | -11673.929% |
| Cerus Corporation | 86.4 Million USD | -3046.664% |
| Envoy Medical, Inc. | -473 Thousand USD | 574881.818% |
| electroCore, Inc. | 13.22 Million USD | -20455.86% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -4456814.754% |
| IceCure Medical Ltd | 1.3 Million USD | -209032.154% |
| Inogen, Inc. | 126.69 Million USD | -2045.809% |
| OrthoPediatrics Corp. | 111.25 Million USD | -2343.726% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 45037.488% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 5743546.848% |
| MaxCyte, Inc. | 36.54 Million USD | -7339.167% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -595434.887% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -3196135.598% |
| Orthofix Medical Inc. | 486.27 Million USD | -459.093% |
| PAVmed Inc | -3.96 Million USD | 68616.079% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 49666.418% |
| RxSight, Inc. | 53.76 Million USD | -4956.669% |
| Sight Sciences, Inc. | 69.17 Million USD | -3830.203% |
| SI-BONE, Inc. | 109.42 Million USD | -2384.663% |
| TELA Bio, Inc. | 40.11 Million USD | -6677.817% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | -1689.372% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -32770.487% |
| Acutus Medical, Inc. | -3.13 Million USD | 86766.178% |
| Talis Biomedical Corporation | 371 Thousand USD | -732708.086% |
| Spectral AI, Inc. | 7.88 Million USD | -34401.497% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 41342.688% |
| CVRx, Inc. | 33.03 Million USD | -8128.814% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -367529.806% |
| Bioventus Inc. | 328.19 Million USD | -728.39% |
| Venus Concept Inc. | 52.16 Million USD | -5111.567% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -16992.405% |
| LivaNova PLC | 771.25 Million USD | -252.508% |
| 908 Devices Inc. | 25.32 Million USD | -10636.585% |
| Alphatec Holdings, Inc. | 310.2 Million USD | -776.432% |
| Nemaura Medical Inc. | -1.47 Million USD | 184246.08% |
| NeuroPace, Inc. | 48.12 Million USD | -5549.636% |
| LENSAR, Inc. | 21.1 Million USD | -12780.646% |
| Apyx Medical Corporation | 14.12 Million USD | -19151.65% |
| Cutera, Inc. | 41.49 Million USD | -6452.075% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -14626.819% |
| BioSig Technologies, Inc. | 18 Thousand USD | -15103888.889% |
| Anika Therapeutics, Inc. | 103.08 Million USD | -2537.279% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -19870.016% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | -206.026% |
| Axonics, Inc. | 274.55 Million USD | -890.231% |
| Outset Medical, Inc. | 29 Million USD | -9274.89% |
| IRIDEX Corporation | 21.8 Million USD | -12367.18% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -3726.539% |
| IRadimed Corporation | 50.15 Million USD | -5320.279% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -947188.502% |
| INVO Bioscience, Inc. | 1.08 Million USD | -250210.55% |
| Telesis Bio, Inc. | 16.95 Million USD | -15939.634% |
| Viemed Healthcare, Inc. | 112.78 Million USD | -2310.574% |
| Varex Imaging Corporation | 256.9 Million USD | -958.279% |
| Quipt Home Medical Corp. | 163.84 Million USD | -1559.323% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 669734.975% |
| Pulmonx Corporation | 50.75 Million USD | -5256.869% |
| Dynatronics Corporation | 7.63 Million USD | -35508.721% |
| Modular Medical, Inc. | -768 Thousand USD | 354099.74% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -48903.569% |
| Semler Scientific, Inc. | 61.2 Million USD | -4342.35% |
| InMode Ltd. | 411.34 Million USD | -560.942% |
| Bruker Corporation | 1.51 Billion USD | -79.24% |
| Cytosorbents Corporation | 22.39 Million USD | -12041.458% |
| DexCom, Inc. | 2.28 Billion USD | -18.778% |
| Viveve Medical, Inc. | 620 Thousand USD | -438402.903% |
| ZimVie Inc. | 290.38 Million USD | -836.252% |
| Movano Inc. | -158 Thousand USD | 1720807.595% |
| Cytek Biosciences, Inc. | 109.42 Million USD | -2384.527% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -3196135.598% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | -639.405% |
| Profound Medical Corp. | 4.51 Million USD | -60128.298% |
| Insulet Corporation | 1.15 Billion USD | -134.392% |
| enVVeno Medical Corporation | -546 Thousand USD | 498033.7% |
| Surmodics, Inc. | 93.05 Million USD | -2821.719% |
| iCAD, Inc. | 14.53 Million USD | -18603.343% |
| Nuwellis, Inc. | 4.98 Million USD | -54459.864% |
| Biotricity, Inc. | 8.35 Million USD | -32435.024% |
| iRhythm Technologies, Inc. | 331.8 Million USD | -719.37% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 757282.843% |
| InspireMD, Inc. | 1.8 Million USD | -150354.787% |
| PAVmed Inc. | -3.96 Million USD | 68616.079% |
| BIOLASE, Inc. | 16.72 Million USD | -16156.385% |
| Beyond Air, Inc. | -1.3 Million USD | 208112.089% |
| FONAR Corporation | 45.14 Million USD | -5922.852% |
| AxoGen, Inc. | 127.87 Million USD | -2026.091% |
| Vivani Medical, Inc. | -357 Thousand USD | 761645.658% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | -1293.264% |
| Inari Medical, Inc. | 434.56 Million USD | -525.62% |
| UFP Technologies, Inc. | 112.22 Million USD | -2322.56% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -21716634.563% |
| Tenon Medical, Inc. | 1.24 Million USD | -218974.778% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 3356541.975% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -103387.853% |
| AdaptHealth Corp. | 479.56 Million USD | -466.915% |
| Sintx Technologies, Inc. | 1.84 Million USD | -147415.898% |
| NanoVibronix, Inc. | 1.53 Million USD | -176784.71% |
| Quanterix Corporation | 70.64 Million USD | -3748.368% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 669734.975% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -19236.543% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -5051.038% |
| TransMedics Group, Inc. | 154.09 Million USD | -1664.336% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -60953.627% |
| NeuroMetrix, Inc. | 3.94 Million USD | -68773.412% |
| Hyperfine, Inc. | 4.75 Million USD | -57051.945% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | -2441.404% |
| Biomerica, Inc. | 611 Thousand USD | -444862.029% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -6421.681% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 348227.357% |
| Silk Road Medical, Inc | 127.08 Million USD | -2039.274% |